TD Asset Management
AZN icon

TD Asset Management’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$63.5M Sell
908,339
-199,851
-18% -$14M 0.05% 268
2025
Q1
$81.5M Sell
1,108,190
-162,735
-13% -$12M 0.08% 226
2024
Q4
$83.3M Sell
1,270,925
-54,880
-4% -$3.6M 0.07% 227
2024
Q3
$103M Sell
1,325,805
-180,623
-12% -$14M 0.09% 194
2024
Q2
$117M Sell
1,506,428
-30,982
-2% -$2.42M 0.11% 171
2024
Q1
$104M Buy
1,537,410
+121,876
+9% +$8.26M 0.1% 192
2023
Q4
$95.3M Sell
1,415,534
-491,359
-26% -$33.1M 0.09% 193
2023
Q3
$129M Buy
1,906,893
+521,503
+38% +$35.3M 0.16% 122
2023
Q2
$99.2M Sell
1,385,390
-145,579
-10% -$10.4M 0.11% 145
2023
Q1
$106M Sell
1,530,969
-86,977
-5% -$6.04M 0.13% 141
2022
Q4
$110M Sell
1,617,946
-723,573
-31% -$49.1M 0.14% 134
2022
Q3
$129M Buy
2,341,519
+295,637
+14% +$16.2M 0.16% 113
2022
Q2
$135M Buy
2,045,882
+379,110
+23% +$25M 0.16% 117
2022
Q1
$111M Buy
1,666,772
+17,913
+1% +$1.19M 0.1% 162
2021
Q4
$96M Buy
1,648,859
+530,595
+47% +$30.9M 0.08% 198
2021
Q3
$67.2M Buy
1,118,264
+128,173
+13% +$7.7M 0.07% 217
2021
Q2
$56.7M Buy
990,091
+186,086
+23% +$10.7M 0.06% 264
2021
Q1
$40M Buy
804,005
+225,217
+39% +$11.2M 0.04% 317
2020
Q4
$28.9M Buy
578,788
+21,226
+4% +$1.06M 0.04% 353
2020
Q3
$30.6M Sell
557,562
-24,929
-4% -$1.37M 0.04% 306
2020
Q2
$30.8M Buy
582,491
+64,132
+12% +$3.39M 0.04% 277
2020
Q1
$23.2M Buy
518,359
+19,617
+4% +$876K 0.04% 305
2019
Q4
$24.9M Sell
498,742
-63,294
-11% -$3.16M 0.04% 346
2019
Q3
$25.1M Sell
562,036
-142,577
-20% -$6.35M 0.04% 328
2019
Q2
$29.1M Sell
704,613
-59,356
-8% -$2.45M 0.04% 310
2019
Q1
$30.9M Sell
763,969
-91,514
-11% -$3.7M 0.05% 285
2018
Q4
$32.5M Sell
855,483
-141,129
-14% -$5.36M 0.06% 259
2018
Q3
$39.4M Sell
996,612
-67,649
-6% -$2.68M 0.06% 258
2018
Q2
$37.4M Buy
1,064,261
+5,356
+0.5% +$188K 0.06% 259
2018
Q1
$37M Buy
1,058,905
+4,896
+0.5% +$171K 0.06% 267
2017
Q4
$36.6M Buy
1,054,009
+152,731
+17% +$5.3M 0.05% 268
2017
Q3
$30.5M Sell
901,278
-4,406
-0.5% -$149K 0.05% 302
2017
Q2
$30.9M Buy
905,684
+5,421
+0.6% +$185K 0.05% 288
2017
Q1
$28M Sell
900,263
-5,655
-0.6% -$176K 0.04% 323
2016
Q4
$24.8M Buy
905,918
+154,408
+21% +$4.22M 0.04% 324
2016
Q3
$24.7M Buy
751,510
+145,093
+24% +$4.77M 0.04% 314
2016
Q2
$18.3M Buy
606,417
+41,259
+7% +$1.25M 0.03% 366
2016
Q1
$15.9M Buy
565,158
+45,506
+9% +$1.28M 0.03% 398
2015
Q4
$17.6M Buy
519,652
+25,563
+5% +$868K 0.04% 358
2015
Q3
$15.7M Buy
494,089
+246,931
+100% +$7.86M 0.03% 371
2015
Q2
$15.7M Buy
247,158
+80,866
+49% +$5.15M 0.03% 388
2015
Q1
$11.4M Buy
166,292
+65,858
+66% +$4.51M 0.02% 464
2014
Q4
$7.07M Buy
100,434
+19,087
+23% +$1.34M 0.01% 582
2014
Q3
$5.81M Buy
81,347
+20,831
+34% +$1.49M 0.01% 612
2014
Q2
$4.5M Sell
60,516
-105,947
-64% -$7.87M 0.01% 680
2014
Q1
$10.8M Sell
166,463
-8,199
-5% -$532K 0.02% 450
2013
Q4
$10.4M Buy
174,662
+24,075
+16% +$1.43M 0.02% 437
2013
Q3
$7.82M Buy
150,587
+141,163
+1,498% +$7.33M 0.02% 487
2013
Q2
$446K Buy
+9,424
New +$446K ﹤0.01% 951